vs
Side-by-side financial comparison of ImmunityBio, Inc. (IBRX) and UNITY BANCORP INC (UNTY). Click either name above to swap in a different company.
ImmunityBio, Inc. is the larger business by last-quarter revenue ($38.3M vs $35.3M, roughly 1.1× UNITY BANCORP INC). UNITY BANCORP INC runs the higher net margin — 43.9% vs -161.8%, a 205.7% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs 24.2%). UNITY BANCORP INC produced more free cash flow last quarter ($44.3M vs $-71.3M).
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
Unity Bancorp Inc is a New Jersey-headquartered financial holding company operating Unity Bank. It offers a full range of commercial and retail banking services including business loans, deposit products, mortgage services, and personal banking solutions, primarily serving small and medium-sized enterprises and individual consumers across local communities in New Jersey and eastern Pennsylvania.
IBRX vs UNTY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $38.3M | $35.3M |
| Net Profit | $-61.9M | $15.5M |
| Gross Margin | 99.0% | — |
| Operating Margin | -169.0% | 55.8% |
| Net Margin | -161.8% | 43.9% |
| Revenue YoY | 407.0% | 24.2% |
| Net Profit YoY | -4.7% | 34.5% |
| EPS (diluted) | $-0.06 | $1.52 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $38.3M | $35.3M | ||
| Q3 25 | $32.1M | $32.8M | ||
| Q2 25 | $26.4M | $34.4M | ||
| Q1 25 | $16.5M | $29.4M | ||
| Q4 24 | $7.6M | $28.4M | ||
| Q3 24 | $6.1M | $27.7M | ||
| Q2 24 | — | $25.5M | ||
| Q1 24 | — | $25.6M |
| Q4 25 | $-61.9M | $15.5M | ||
| Q3 25 | $-67.3M | $14.4M | ||
| Q2 25 | $-92.6M | $16.5M | ||
| Q1 25 | $-129.6M | $11.6M | ||
| Q4 24 | $-59.2M | $11.5M | ||
| Q3 24 | $-85.7M | $10.9M | ||
| Q2 24 | — | $9.5M | ||
| Q1 24 | — | $9.6M |
| Q4 25 | 99.0% | — | ||
| Q3 25 | 99.4% | — | ||
| Q2 25 | 99.5% | — | ||
| Q1 25 | 99.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -169.0% | 55.8% | ||
| Q3 25 | -173.5% | 57.5% | ||
| Q2 25 | -269.8% | 62.6% | ||
| Q1 25 | -390.1% | 52.6% | ||
| Q4 24 | -919.0% | 51.0% | ||
| Q3 24 | -1314.3% | 52.7% | ||
| Q2 24 | — | 49.3% | ||
| Q1 24 | — | 50.0% |
| Q4 25 | -161.8% | 43.9% | ||
| Q3 25 | -209.8% | 43.8% | ||
| Q2 25 | -350.3% | 48.0% | ||
| Q1 25 | -784.9% | 39.5% | ||
| Q4 24 | -783.4% | 40.5% | ||
| Q3 24 | -1404.0% | 39.4% | ||
| Q2 24 | — | 37.1% | ||
| Q1 24 | — | 37.5% |
| Q4 25 | $-0.06 | $1.52 | ||
| Q3 25 | $-0.07 | $1.41 | ||
| Q2 25 | $-0.10 | $1.61 | ||
| Q1 25 | $-0.15 | $1.13 | ||
| Q4 24 | $-0.08 | $1.13 | ||
| Q3 24 | $-0.14 | $1.07 | ||
| Q2 24 | — | $0.92 | ||
| Q1 24 | — | $0.94 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $242.8M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-500.5M | $345.6M |
| Total Assets | $501.9M | $3.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $242.8M | — | ||
| Q3 25 | $257.8M | — | ||
| Q2 25 | $153.7M | — | ||
| Q1 25 | $61.6M | — | ||
| Q4 24 | $149.8M | — | ||
| Q3 24 | $130.4M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $230.8M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-500.5M | $345.6M | ||
| Q3 25 | $-524.3M | $334.0M | ||
| Q2 25 | $-570.7M | $319.8M | ||
| Q1 25 | $-591.4M | $306.1M | ||
| Q4 24 | $-489.1M | $295.6M | ||
| Q3 24 | $-745.1M | $284.3M | ||
| Q2 24 | — | $273.4M | ||
| Q1 24 | — | $266.8M |
| Q4 25 | $501.9M | $3.0B | ||
| Q3 25 | $519.0M | $2.9B | ||
| Q2 25 | $402.1M | $2.9B | ||
| Q1 25 | $303.8M | $2.8B | ||
| Q4 24 | $382.9M | $2.7B | ||
| Q3 24 | $364.6M | $2.6B | ||
| Q2 24 | — | $2.6B | ||
| Q1 24 | — | $2.6B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-70.4M | $44.9M |
| Free Cash FlowOCF − Capex | $-71.3M | $44.3M |
| FCF MarginFCF / Revenue | -186.2% | 125.7% |
| Capex IntensityCapex / Revenue | 2.4% | 1.6% |
| Cash ConversionOCF / Net Profit | — | 2.90× |
| TTM Free Cash FlowTrailing 4 quarters | $-308.8M | $81.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-70.4M | $44.9M | ||
| Q3 25 | $-68.9M | $45.5M | ||
| Q2 25 | $-79.7M | $-25.3M | ||
| Q1 25 | $-85.9M | $17.9M | ||
| Q4 24 | $-85.1M | $48.0M | ||
| Q3 24 | $-98.8M | $17.7M | ||
| Q2 24 | — | $-8.4M | ||
| Q1 24 | — | $15.8M |
| Q4 25 | $-71.3M | $44.3M | ||
| Q3 25 | $-69.6M | $45.3M | ||
| Q2 25 | $-80.8M | $-25.5M | ||
| Q1 25 | $-87.0M | $17.6M | ||
| Q4 24 | $-87.3M | $47.3M | ||
| Q3 24 | $-101.6M | $17.5M | ||
| Q2 24 | — | $-8.6M | ||
| Q1 24 | — | $15.7M |
| Q4 25 | -186.2% | 125.7% | ||
| Q3 25 | -217.2% | 138.1% | ||
| Q2 25 | -305.9% | -74.2% | ||
| Q1 25 | -526.9% | 59.9% | ||
| Q4 24 | -1155.4% | 166.5% | ||
| Q3 24 | -1663.2% | 63.3% | ||
| Q2 24 | — | -33.7% | ||
| Q1 24 | — | 61.4% |
| Q4 25 | 2.4% | 1.6% | ||
| Q3 25 | 2.3% | 0.7% | ||
| Q2 25 | 4.1% | 0.5% | ||
| Q1 25 | 6.8% | 1.0% | ||
| Q4 24 | 28.0% | 2.4% | ||
| Q3 24 | 45.7% | 0.5% | ||
| Q2 24 | — | 0.5% | ||
| Q1 24 | — | 0.3% |
| Q4 25 | — | 2.90× | ||
| Q3 25 | — | 3.16× | ||
| Q2 25 | — | -1.54× | ||
| Q1 25 | — | 1.54× | ||
| Q4 24 | — | 4.17× | ||
| Q3 24 | — | 1.62× | ||
| Q2 24 | — | -0.89× | ||
| Q1 24 | — | 1.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
